PT  - JOURNAL ARTICLE
AU  - Mrema, Lucy Elauteri
AU  - Mapunda, Anthony
AU  - Sylvester, Pauline
AU  - Olomi, Willyhelmina
AU  - Ntinginya, Nyanda Elias
AU  - Mayige, Mary
TI  - Type 1 Diabetes Mellitus in Tanzania: a systematic review of prevalence and incidence
AID  - 10.1101/2024.10.09.24315148
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.10.09.24315148
4099  - http://medrxiv.org/content/early/2024/10/09/2024.10.09.24315148.short
4100  - http://medrxiv.org/content/early/2024/10/09/2024.10.09.24315148.full
AB  - Objective Type 1 diabetes mellitus (T1DM) is a chronic disease that affects children and adolescents globally. However, there is a paucity of data on the incidence and prevalence T1DM in Tanzania. This systematic review aimed to determine the prevalence and incidence of type 1 diabetes mellitus Tanzania through a comprehensive review of available literature.Methods A systematic literature search was conducted in six electronic databases (PubMed, Scopus, Web of Science, Embase, African Journals Online, and Tanzania Medical Journal) to identify studies reporting on the prevalence and incidence of T1DM in Tanzania. The search was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.Results A total of 63 studies were identified through the initial search, of which two studies met the inclusion criteria. Both studies were conducted in Dar es Salaam, Mwanza, Zanzibar, Kilimanjaro Tanzania, and reported on the incidence and prevalence of T1DM in children and adolescents. The studies were published in 1993 and 2019, respectively. The first study reported an annual incidence of T1DM of 1.5 per 100,000 population aged 0-19 years, while the second study reported an annual incidence ranging from 1.8 to 1.9 per 100,000 children and a prevalence ranging from 10.1 to 11.9 per 100,000 children.Conclusion The prevalence and incidence of T1DM in Tanzania are relatively low, based on the limited evidence available. More prevalence and incidence studies are needed to provide a better understanding of the burden of T1DM to inform diabetes management strategies in the country.Ethics Since this review has used previously published studies, consent of an ethics committee was not sought.PROSPERO registration number CRD42022369954.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets used for analysis in this systematic review are available upon reasonable request.